Tekla Capital Management LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2020$1,081,000
-30.0%
41,5770.0%0.04%
-34.5%
Q3 2020$1,545,000
-27.6%
41,5770.0%0.06%
-28.4%
Q2 2020$2,133,000
+62.7%
41,5770.0%0.08%
+37.3%
Q1 2020$1,311,000
-89.7%
41,577
-80.5%
0.06%
-87.8%
Q4 2019$12,735,000
+62.7%
213,5620.0%0.48%
+40.9%
Q3 2019$7,829,000
-8.8%
213,562
+15.7%
0.34%
-2.3%
Q2 2019$8,588,000
+15.9%
184,6070.0%0.35%
+16.3%
Q1 2019$7,412,000
+13.2%
184,607
+29.7%
0.30%
+7.5%
Q4 2018$6,545,000
-22.1%
142,289
-24.8%
0.28%
-8.2%
Q3 2018$8,399,000
+13.2%
189,2870.0%0.30%
+8.5%
Q2 2018$7,418,000
-45.8%
189,2870.0%0.28%
-47.2%
Q1 2018$13,691,000
+963.8%
189,287
+84.1%
0.53%
+867.3%
Q4 2016$1,287,000
-9.6%
102,8000.0%0.06%0.0%
Q3 2016$1,424,000
+40.2%
102,8000.0%0.06%
+34.1%
Q2 2016$1,016,000
-41.5%
102,8000.0%0.04%
-44.6%
Q1 2016$1,738,000
-24.0%
102,8000.0%0.07%
-10.8%
Q4 2015$2,288,000
-52.8%
102,800
-50.0%
0.08%
-52.3%
Q3 2015$4,850,000
-80.0%
205,600
-30.5%
0.17%
-80.1%
Q2 2015$24,200,000296,0000.88%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders